124 related articles for article (PubMed ID: 6536662)
1. Adverse effects in donors and patients subjected to hemapheresis.
Huestis DW
J Clin Apher; 1984; 2(1):81-90. PubMed ID: 6536662
[No Abstract] [Full Text] [Related]
2. Multiple pheresis - effect on the donor.
Ho W
Prog Clin Biol Res; 1981; 65():91-9. PubMed ID: 7330074
[No Abstract] [Full Text] [Related]
3. [Side effects of thrombocytapheresis and leukocytapheresis in healthy donors].
Höcker P; Wagner A; Puffer G; Michl U
Beitr Infusionther Klin Ernahr; 1987; 18():205-9. PubMed ID: 3439974
[No Abstract] [Full Text] [Related]
4. Health risk of leukapheresis donors.
Sandler SG; Nusbacher J
Haematologia (Budap); 1982; 15(1):57-69. PubMed ID: 6180961
[TBL] [Abstract][Full Text] [Related]
5. Clinical and laboratory effects on donors of intermittent-flow centrifugation platelet-leukapheresis performed with hydroxyethyl starch and citrate.
Strauss RG; Koepke JA; Maguire LC; Thompson JS
Clin Lab Haematol; 1980; 2(1):1-11. PubMed ID: 6155239
[No Abstract] [Full Text] [Related]
6. Health risks to cytapheresis donors.
Westphal RG
Clin Haematol; 1984 Feb; 13(1):289-301. PubMed ID: 6202448
[TBL] [Abstract][Full Text] [Related]
7. [The apheresis: plasmapheresis, plateletpheresis, leukapheresis. Physiopathology of the donor (author's transl)].
Avanzi G
Pathologica; 1978; 70(1007-1008):467-80. PubMed ID: 370755
[No Abstract] [Full Text] [Related]
8. [Hemolysis following cytapheresis. 2 cases].
Schooneman F; Janot C; Streiff F
Nouv Presse Med; 1980 Feb; 9(8):540. PubMed ID: 7367294
[No Abstract] [Full Text] [Related]
9. Cytapheresis and plasmapheresis.
Mishler JM
Blood; 1984 Jul; 64(1):321-2. PubMed ID: 6733282
[No Abstract] [Full Text] [Related]
10. [Adverse effects of hemapheresis].
Bláha M; Jebavý L; Siroký O; Malý J; Pecka M
Vnitr Lek; 1989 Oct; 35(10):972-81. PubMed ID: 2617884
[TBL] [Abstract][Full Text] [Related]
11. Normal donor monitoring standards.
Menitove JE; Grindon AJ; Nusbacher J; Price TH; Aster RH
J Clin Apher; 1983; 1(3):124-9. PubMed ID: 6546051
[No Abstract] [Full Text] [Related]
12. Donor symptomatology and safety in blood cell separation procedures.
Hester JP
Prog Clin Biol Res; 1982; 88():115-24. PubMed ID: 6179100
[TBL] [Abstract][Full Text] [Related]
13. Peripheral blood lymphocyte numbers, lymphocyte proliferative responses in vitro, and serum immunoglobulins in regular hemapheresis donors.
Braine HG; Elfenbein GJ; Mellits ED
J Clin Apher; 1985; 2(3):213-8. PubMed ID: 4030708
[TBL] [Abstract][Full Text] [Related]
14. Anticoagulation and electrolytes.
Hester JP; Ayyar R
J Clin Apher; 1984; 2(1):41-51. PubMed ID: 6536658
[No Abstract] [Full Text] [Related]
15. [Complications and adverse effects of plasmapheresis and their incidences].
Yuasa S
Nihon Rinsho; 1984 Aug; 42(8):1920-9. PubMed ID: 6392614
[No Abstract] [Full Text] [Related]
16. Donor hemapheresis in France at the start of 1992.
Coffe C; Norol F
Transfus Sci; 1993 Apr; 14(2):163-4. PubMed ID: 10150147
[No Abstract] [Full Text] [Related]
17. Cellular depletion by apheresis.
Strauss RG; Huestis DW; Wright DG; Hester JP
J Clin Apher; 1983; 1(3):158-65. PubMed ID: 6546054
[No Abstract] [Full Text] [Related]
18. Applications and limitations of hemapheresis.
Silvergleid AJ
Annu Rev Med; 1983; 34():69-89. PubMed ID: 6344778
[TBL] [Abstract][Full Text] [Related]
19. Acute hemolytic transfusion reaction due to ABO incompatible plasma in a plateletapheresis concentrate.
Conway LT; Scott EP
Transfusion; 1984; 24(5):413-4. PubMed ID: 6485086
[No Abstract] [Full Text] [Related]
20. Current status of leukocyte and platelet administration in cancer therapy.
Walker EM; Cannon A; Mitchum EN
Ann Clin Lab Sci; 1983; 13(6):453-73. PubMed ID: 6197928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
